DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 178 filers reported holding DICERNA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $5,000 | 0.0% | 266 | +88.7% | 0.00% | – |
| Q2 2021 | $5,000 | +25.0% | 141 | 0.0% | 0.00% | – |
| Q1 2021 | $4,000 | +33.3% | 141 | 0.0% | 0.00% | – |
| Q4 2020 | $3,000 | -62.5% | 141 | -66.6% | 0.00% | – |
| Q3 2020 | $8,000 | +14.3% | 422 | +9.3% | 0.00% | – |
| Q2 2020 | $7,000 | 0.0% | 386 | 0.0% | 0.00% | – |
| Q1 2020 | $7,000 | -22.2% | 386 | 0.0% | 0.00% | – |
| Q4 2019 | $9,000 | +50.0% | 386 | -11.5% | 0.00% | – |
| Q3 2019 | $6,000 | 0.0% | 436 | +9.3% | 0.00% | – |
| Q2 2019 | $6,000 | 0.0% | 399 | 0.0% | 0.00% | – |
| Q1 2019 | $6,000 | 0.0% | 399 | -33.5% | 0.00% | – |
| Q4 2018 | $6,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,705,392 | $43,607,000 | 7.88% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $78,762,000 | 4.46% |
| DAFNA Capital Management LLC | 587,756 | $15,029,000 | 3.57% |
| RTW INVESTMENTS, LP | 7,463,291 | $190,836,000 | 2.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $5,114,000 | 2.79% |
| Evolutionary Tree Capital Management, LLC | 122,473 | $3,132,000 | 1.85% |
| Parkman Healthcare Partners LLC | 303,268 | $7,755,000 | 1.80% |
| Eagle Health Investments LP | 161,125 | $4,120,000 | 1.62% |
| BRIDGER MANAGEMENT, LLC | 588,910 | $15,058,000 | 1.41% |
| Woodline Partners LP | 1,777,000 | $45,438,000 | 1.01% |